Geert Bezemer

436 total citations
8 papers, 91 citations indexed

About

Geert Bezemer is a scholar working on Hepatology, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, Geert Bezemer has authored 8 papers receiving a total of 91 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 4 papers in Epidemiology and 2 papers in Psychiatry and Mental health. Recurrent topics in Geert Bezemer's work include Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hepatitis B Virus Studies (2 papers). Geert Bezemer is often cited by papers focused on Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hepatitis B Virus Studies (2 papers). Geert Bezemer collaborates with scholars based in Netherlands, Sweden and Israel. Geert Bezemer's co-authors include Robert J. de Knegt, Arthur R. Van Gool, Bettina E. Hansen, Harry L.A. Janssen, Joost P.H. Drenth, M. W. Hengeveld, H.A. Droogleever Fortuyn, Solko W. Schalm, Christine J. Weegink and Stefan Zeuzem and has published in prestigious journals such as Alimentary Pharmacology & Therapeutics, The Journal of Clinical Psychiatry and Clinical Immunology.

In The Last Decade

Geert Bezemer

8 papers receiving 91 citations

Peers

Geert Bezemer

EPIDE

HEPAT

IMMUN

BP

PMH

Doina Istrătescu Romania

Lindsay Kosack Austria

Mirta Peralta Argentina

Carlos Brodersen Argentina

Asma Labidi Tunisia

Ben Hammoud Germany

Cody Connor United States

Parveen Rewri India

Giuseppe Francesco Casciaro Italy

Brian A. McFerron United States

Doina Istrătescu Romania

Geert Bezemer

45 ×0.9

EPIDE

32 ×0.6

HEPAT

6 ×0.3

IMMUN

2 ×0.1

BP

4 ×0.4

PMH

Citations per year, relative to Geert Bezemer Geert Bezemer (= 1×) peers Doina Istrătescu

Countries citing papers authored by Geert Bezemer

Since Specialization

Citations

This map shows the geographic impact of Geert Bezemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geert Bezemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geert Bezemer more than expected).

Fields of papers citing papers by Geert Bezemer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geert Bezemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geert Bezemer. The network helps show where Geert Bezemer may publish in the future.

Co-authorship network of co-authors of Geert Bezemer

This figure shows the co-authorship network connecting the top 25 collaborators of Geert Bezemer. A scholar is included among the top collaborators of Geert Bezemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geert Bezemer. Geert Bezemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Brakenhoff, Sylvia M., Pieter Honkoop, Jan G. den Hollander, et al.. (2022). Patients treated with rituximab are poorly screened for hepatitis B infection: Data from a low-incidence country. European Journal of Internal Medicine. 108. 68–73. 1 indexed citations

2.

West, Rachel, Maurice G. Rüssel, Alexander Bodelier, et al.. (2022). Lower Risk of Recurrence with a Higher Induction Dose of Mesalazine and Longer Duration of Treatment in Ulcerative Colitis: Results from the Dutch, Non-Interventional, IMPACT Study. Journal of Gastrointestinal and Liver Diseases. 31(1). 18–24. 5 indexed citations

3.

Bezemer, Geert, Bettina E. Hansen, Arthur R. Van Gool, et al.. (2014). Effects of Escitalopram Prophylaxis During Antiviral Treatment for Chronic Hepatitis C in Patients With a History of Intravenous Drug Use and Depression. The Journal of Clinical Psychiatry. 75(10). 1069–1077. 2 indexed citations

4.

Bezemer, Geert, Arthur R. Van Gool, Bettina E. Hansen, et al.. (2012). Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study. BMC Gastroenterology. 12(1). 11–11. 31 indexed citations

5.

Bezemer, Geert, Arthur R. Van Gool, Durk Fekkes, et al.. (2012). Psychiatric Side Effects and Fluctuations in Serotonergic Parameters in the Treatment of Chronic Hepatitis C Infection. Neuropsychobiology. 65(3). 126–132. 7 indexed citations

6.

Knegt, Robert J. de, Geert Bezemer, Arthur R. Van Gool, et al.. (2011). Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon‐alfa‐2a and ribavirin for chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 34(11-12). 1306–1317. 26 indexed citations

7.

Bezemer, Geert, S W Schalm, Arthur R. Van Gool, & Robert J. de Knegt. (2007). [Changes in the management of patients with side effects from the treatment of hepatitis C].. PubMed. 151(9). 525–30. 2 indexed citations

8.

Mancham, Shanta, Rekha S. Binda, Geert Bezemer, et al.. (2003). Human hepatic lymph nodes contain normal numbers of mature myeloid dendritic cells but few plasmacytoid dendritic cells. Clinical Immunology. 110(1). 81–88. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact